| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Christine Garvey is Director at TOL, with reported holdings spanning 2 companies. Christine Garvey's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.9M at current prices.
Our model assigns Christine Garvey a middling insider score of 54/100, based on 18 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -15.6%.
Christine Garvey's largest disclosed position is in TOL as Director, worth about $1.8M. The TOL filings lean toward selling, a net 86,923 shares.
Christine Garvey has 90 Form 4 filings on record from January 2015 to January 2026, across 2 companies: Director at Toll Brothers (TOL), 2015–2026; Director at Healthpeak Properties (DOC), 2015–2023.
The 147 reported transactions were 74 gifts, 27 open-market sales, 22 option exercises and 13 option or other derivative awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $269 and 26 sales worth about $4.3M.
The only open-market purchase was 9 shares of TOL at an average $29.87 on October 26, 2018, about $269.
The largest open-market sale was 41,000 shares of TOL at an average $33.24 on December 14, 2015, about $1.4M.
None of the 7 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 14, 2025 | TOL Toll Brothers, Inc. | Director | Sell | 770 | $119.82 | $92,258.01 | -6.2% | +7.0% | +25.3% | |
| Feb 24, 2025 | TOL Toll Brothers, Inc. | Director | Sell | 420 | $110.59 | $46,445.70 | -3.1% | -2.4% | +44.4% | |
| Dec 30, 2024 | TOL Toll Brothers, Inc. | Director | Sell | 204 | $125.78 | $25,659.12 | -2.6% | -16.3% | +8.3% | |
| Dec 24, 2024 | TOL Toll Brothers, Inc. | Director | Sell | 21 | $126.77 | $2,662.07 | -0.3% | -13.8% | +9.2% | |
| May 24, 2024 | TOL Toll Brothers, Inc. | Director | Sell | 170 | $121.99 | $20,737.45 | -2.0% | +14.9% | -15.2% | |
| Feb 22, 2024 | TOL Toll Brothers, Inc. | Director | Sell | 2,160 | $110.75 | $239,229.72 | -19.8% | +8.5% | +1.5% | |
| Apr 12, 2023 | TOL Toll Brothers, Inc. | Director | Sell | 2,980 | $60.14 | $179,202.30 | -26.5% | +34.4% | +102.3% | |
| Mar 2, 2023 | TOL Toll Brothers, Inc. | Director | Sell | 125 | $58.86 | $7,356.88 | -1.1% | +14.4% | +97.6% | |
| Feb 23, 2023 | TOL Toll Brothers, Inc. | Director | Sell | 910 | $57.98 | $52,762.07 | -7.0% | +10.5% | +89.0% | |
| Feb 22, 2023 | DOC Healthpeak Properties, Inc. | Director | Sell | 1,200 | $25.45 | $30,539.40 | -5.0% | -19.7% | -33.1% |